Cargando…

Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective

Despite significant reduction in childhood mortality, infant – particularly neonatal – mortality continues to be unacceptably high. A substantial proportion of these deaths could be averted by vaccinating mothers during pregnancy (maternal immunization). However, in order to realize the full life-sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Sadaf, Fleming, Jessica A., Engmann, Cyril M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920248/
https://www.ncbi.nlm.nih.gov/pubmed/33759694
http://dx.doi.org/10.1080/21645515.2020.1865047
_version_ 1784669086454644736
author Khan, Sadaf
Fleming, Jessica A.
Engmann, Cyril M.
author_facet Khan, Sadaf
Fleming, Jessica A.
Engmann, Cyril M.
author_sort Khan, Sadaf
collection PubMed
description Despite significant reduction in childhood mortality, infant – particularly neonatal – mortality continues to be unacceptably high. A substantial proportion of these deaths could be averted by vaccinating mothers during pregnancy (maternal immunization). However, in order to realize the full life-saving potential of maternal immunization, it is important to develop clear introduction and delivery strategies for maternal vaccines. This will necessitate close collaboration between maternal health and immunization stakeholders. This article examines key considerations and areas for action to support successful and sustainable introduction and scale-up of maternal immunization, from the perspective of maternal, newborn, child, and adolescent health stakeholders.
format Online
Article
Text
id pubmed-8920248
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-89202482022-03-15 Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective Khan, Sadaf Fleming, Jessica A. Engmann, Cyril M. Hum Vaccin Immunother Licensed Vaccines – Commentary Despite significant reduction in childhood mortality, infant – particularly neonatal – mortality continues to be unacceptably high. A substantial proportion of these deaths could be averted by vaccinating mothers during pregnancy (maternal immunization). However, in order to realize the full life-saving potential of maternal immunization, it is important to develop clear introduction and delivery strategies for maternal vaccines. This will necessitate close collaboration between maternal health and immunization stakeholders. This article examines key considerations and areas for action to support successful and sustainable introduction and scale-up of maternal immunization, from the perspective of maternal, newborn, child, and adolescent health stakeholders. Taylor & Francis 2021-03-24 /pmc/articles/PMC8920248/ /pubmed/33759694 http://dx.doi.org/10.1080/21645515.2020.1865047 Text en © 2021 PATH. Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Licensed Vaccines – Commentary
Khan, Sadaf
Fleming, Jessica A.
Engmann, Cyril M.
Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
title Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
title_full Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
title_fullStr Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
title_full_unstemmed Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
title_short Maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
title_sort maternal vaccines: ten considerations for vaccine introduction and scale-up in low- and middle-income countries from the maternal, newborn, child, and adolescent health perspective
topic Licensed Vaccines – Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920248/
https://www.ncbi.nlm.nih.gov/pubmed/33759694
http://dx.doi.org/10.1080/21645515.2020.1865047
work_keys_str_mv AT khansadaf maternalvaccinestenconsiderationsforvaccineintroductionandscaleupinlowandmiddleincomecountriesfromthematernalnewbornchildandadolescenthealthperspective
AT flemingjessicaa maternalvaccinestenconsiderationsforvaccineintroductionandscaleupinlowandmiddleincomecountriesfromthematernalnewbornchildandadolescenthealthperspective
AT engmanncyrilm maternalvaccinestenconsiderationsforvaccineintroductionandscaleupinlowandmiddleincomecountriesfromthematernalnewbornchildandadolescenthealthperspective